S&P 500 futures inch higher after benchmark snaps losing streak, Palantir pops on earnings: Live updates

S&P 500 futures inch higher after benchmark snaps losing streak, Palantir pops on earnings: Live updates


Traders work at the New York Stock Exchange on July 30, 2025.

NYSE

Stock futures were slightly higher on Monday night, following Wall Street’s rebound, as investors followed the latest batch of corporate earnings.

Dow Jones Industrial Average futures added 54 points, or 0.1%. S&P 500 futures and Nasdaq 100 futures each also added 0.1%.

In extended trading, Palantir shares jumped more than 3% as the defense technology company said revenue surpassed $1 billion for the first time. On the other hand, Hims & Hers Health fell more than 13% after second-quarter revenue missed Wall Street’s expectations.

Monday night’s moves come after a winning day on Wall Street that allowed stocks to recover losses from the prior session. The market tanked on Friday as the latest policy rollout on tariffs and a weak jobs report left investors questioning the health of the economy. All three of the major indexes ended the week in the red.

But the S&P 500 was able to jump about 1.5% on Monday, snapping a four-day losing streak. More than four out of every five members of the benchmark average advanced in the session.

The technology-heavy Nasdaq Composite surged nearly 2%, while the Dow climbed about 585 points to erase its Friday loss. The small-cap focused Russell 2000 jumped more than 2%.

“You have to respect the momentum that the market has had. We’re still in a very powerful uptrend,” said Cameron Dawson, investing chief at New Edge Wealth, on CNBC’s “Closing Bell.” But, “it wouldn’t be surprising to see some chop as we move through August.”

Investors on Tuesday will watch for more earnings reports. Pfizer, Yum! Brands and Fox are among the companies reporting before the bell, followed by Snap, Advanced Micro Devices and Rivian after the close.

They’ll also monitor economic data on the trade deficit and purchasing due Tuesday morning.



Source

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
World

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images The Wegovy pill showed more pronounced weight loss and less cumbersome side effects than Eli Lilly‘s rival pill that was approved this week, Novo Nordisk said Thursday.  Oral Wegovy demonstrated “significantly greater mean weight loss” than orforglipron, which Lilly will sell under the […]

Read More
Trump’s Iran timeline may not be short enough to avoid oil demand destruction
World

Trump’s Iran timeline may not be short enough to avoid oil demand destruction

Vehicles have their gasoline tanks filled at a Costco Wholesale store on March 21, 2026, in Bayonne, New Jersey. Gary Hershorn | Corbis News | Getty Images U.S. President Donald Trump says he’ll end the war within weeks, but fears for oil supply and demand destruction are set to linger. In an address on Wednesday […]

Read More
Macquarie: India could emerge as an ‘AI powerhouse’ and names top stocks to watch
World

Macquarie: India could emerge as an ‘AI powerhouse’ and names top stocks to watch

Despite being a global software powerhouse, India has been perceived as a laggard in the artificial intelligence space, with no current domestic chip industry or full-scale foundational AI model . But that narrative is set to change, according to Macquarie. The narrative of India as an AI bystander could shift to it being an “AI […]

Read More